{
    "clinical_study": {
        "@rank": "68930", 
        "arm_group": [
            {
                "arm_group_label": "High Activity Group", 
                "arm_group_type": "Experimental", 
                "description": "Subject randomized to High Activity group will have 36, one hour training sessions over 12 weeks."
            }, 
            {
                "arm_group_label": "Standard of Care Group", 
                "arm_group_type": "No Intervention", 
                "description": "The standard of care group will maintain their baseline level of activity for 12 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to see if a twelve-week exercise intervention in overweight\n      subjects with pre-diabetes can lead to improved skeletal muscle capillary blood flow by\n      improving substances that dilate blood vessels and result in improved insulin sensitivity."
        }, 
        "brief_title": "Physical Activity and Obesity", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Obesity", 
            "Prediabetic State", 
            "Sedentary Lifestyle"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Insulin Resistance", 
                "Obesity", 
                "Prediabetic State"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Males and females ages 30-60 years of age\n\n          2. Obese (30 < BMI <35)\n\n          3. Confirmed pre-diabetic (5.7\u2264 HbA1c < 6.5)\n\n        Exclusion Criteria:\n\n          1. Stage 3 chronic kidney disease (glomerular filtration rate [GFR] < 60)\n\n          2. Obstructive Coronary artery disease\n\n          3. Congestive heart failure (ejection fraction < 55%)\n\n          4. Peripheral vascular disease,\n\n          5. Degenerative joint disease, musculoskeletal disease, or peripheral vascular disease\n             that limits ability to exercise\n\n          6. Know hypersensitivity to Definity\u00ae ultrasound contrast agent\n\n          7. Intra-cardiac or pulmonary shunt\n\n          8. The use of antithrombotic agents or a severe bleeding diathesis due to risk of\n             bleeding with intravenous and arterial line placement\n\n          9. Physical activity greater than three hours per week\n\n         10. Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "30 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 6, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02060240", 
            "org_study_id": "OHSUIRB#10299", 
            "secondary_id": "5KL2TR000152-08"
        }, 
        "intervention": {
            "arm_group_label": "High Activity Group", 
            "description": "The high activity group will undergo a 12 week ramped exercise protocol.", 
            "intervention_name": "High Activity", 
            "intervention_type": "Behavioral"
        }, 
        "intervention_browse": {
            "mesh_term": "Nitric Oxide"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Obesity", 
            "Prediabetic State", 
            "Sedentary Lifestyle", 
            "Insulin Resistance", 
            "Endothelium", 
            "Eicosanoids", 
            "Nitric Oxide", 
            "Regional Blood Flow"
        ], 
        "lastchanged_date": "February 7, 2014", 
        "link": {
            "description": "Physical Activity and Obesity Trial Information", 
            "url": "http://www.ohsu.edu/research/rda/so/knight_viewstudy.php?id=IRB00010299&WT_rank=1"
        }, 
        "location": {
            "contact": {
                "email": "chadderd@ohsu.edu", 
                "last_name": "Scott M Chadderdon, MD", 
                "phone": "503-494-8750"
            }, 
            "facility": {
                "address": {
                    "city": "Portland", 
                    "country": "United States", 
                    "state": "Oregon", 
                    "zip": "97239"
                }, 
                "name": "Oregon Health & Science University"
            }, 
            "investigator": {
                "last_name": "Scott M Chadderdon, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Physical Activity and Obesity: The Role of Nitric Oxide and Eicosanoids in Regulating Capillary Perfusion and Vascular Insulin Resistance", 
        "other_outcome": {
            "description": "Aim 3.\tTo correlate changes in fitness as measured by peak VO2 and anaerobic threshold during cardiopulmonary exercise testing with changes in endothelial derived vasodilators, skeletal muscle blood flow, and insulin sensitivity.", 
            "measure": "Correalte changes in fitness to vasodilators, blood flow, and insulin sensitivity", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "overall_contact": {
            "email": "chadderd@ohsu.edu", 
            "last_name": "Scott M Chadderdon, MD", 
            "phone": "503-494-8750"
        }, 
        "overall_contact_backup": {
            "email": "haas@ohsu.edu", 
            "last_name": "Kate Haas", 
            "phone": "503-494-4786"
        }, 
        "overall_official": {
            "affiliation": "Oregon Health and Science University", 
            "last_name": "Scott M Chadderdon, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Contrast enhanced ultrasound skeltal muscle perfusion imaging will be performed at rest and during glucose steady state infusion during an insulin clamp. The change in blood flow will be determined between the resting state and at peak steady state to determine the absolute increase in skeletal muslce blood flow  (ml/min/g) as well as the absolute increase in capillary blood volume (ml/g) of tissue", 
            "measure": "Insulin mediated skeletal muslce blood flow and capillary recruitment", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "reference": [
            {
                "PMID": "22739105", 
                "citation": "Chadderdon SM, Belcik JT, Smith E, Pranger L, Kievit P, Grove KL, Lindner JR. Activity restriction, impaired capillary function, and the development of insulin resistance in lean primates. Am J Physiol Endocrinol Metab. 2012 Sep 1;303(5):E607-13. doi: 10.1152/ajpendo.00231.2012. Epub 2012 Jun 26."
            }, 
            {
                "PMID": "11723050", 
                "citation": "Coggins M, Lindner J, Rattigan S, Jahn L, Fasy E, Kaul S, Barrett E. Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes. 2001 Dec;50(12):2682-90."
            }, 
            {
                "PMID": "16644702", 
                "citation": "Clerk LH, Vincent MA, Jahn LA, Liu Z, Lindner JR, Barrett EJ. Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle. Diabetes. 2006 May;55(5):1436-42."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02060240"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Oregon Health and Science University", 
            "investigator_full_name": "Scott M. Chadderdon", 
            "investigator_title": "Assistant Professor Cardiovascular Medicine", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "To quantify the changes in endothelial derived vasodilators. For this aim nitric oxide bioavailability as tested by flow mediated vasodilation will be perforemd  and reproted as asolute and percent chagne in bradhial artery diameter after ischemic occlusion of the forearm. Plasma samples for eicosanoids  will be collected  and assessed by liquid chormatography/mass spectroscopy to to assess changes in endothelial derived vasodilators.", 
            "measure": "Quantification of endothelial derived Vasodilators", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "source": "Oregon Health and Science University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Oregon Health and Science University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}